Physician

Charles J Eldredge, M.D.

According to 2025 Medicare claims, Charles Eldredge, M.D. (NPI: 1215989322) practices nephrology in the Utica-Rome, NY market, with the plurality of this provider's patient population coming from Oneida, NY. This provider's primary affiliated billing organization is MOHAWK VALLEY NEPHROLOGY ASSOCIATES, LLP (NPI: 1548287329; TIN: 201188601) and primary practice location at 13502-4830. Eldredge is affiliated with the Bassett Accountable Care Partners, LLC (ACO ID: A2612), Trinity Health Integrated Care (ACO ID: A3454), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Eldredge's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 551 traditional Medicare patients, billed 3,043 HCPCS/CPT codes, and received $278,182 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 396 prescription claims across 127 beneficiaries totaling $97,132 in drug costs, led by Potassium Chloride (Potassium Chloride). DME data shows 23 claims. Open Payments data shows 11 records totaling $340. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have fallen sharply in recent years, from $379,483 to $97,132. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $5,572 and ending at $1,047.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	553	3,704	$340,263
2016	557	3,640	$312,697
2017	627	4,374	$376,587
2018	684	4,700	$430,732
2019	703	5,918	$484,106
2020	617	5,257	$415,203
2021	608	3,954	$396,745
2022	596	4,397	$357,481
2023	564	3,846	$309,751
2024	551	3,043	$278,182

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	294	3,471	$379,483
2016	282	3,132	$355,689
2017	315	3,448	$406,558
2018	350	2,973	$248,698
2019	321	2,436	$221,348
2020	241	1,461	$135,183
2021	224	1,136	$127,950
2022	158	720	$70,175
2023	119	293	$30,732
2024	127	396	$97,132

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	314	$37,542
2016	N/R	220	$23,060
2017	N/R	215	$18,066
2018	N/R	131	$8,208
2019	N/R	14	$713
2020	N/R	17	$1,323
2021	N/R	30	$1,338
2022	N/R	74	$3,928
2023	N/R	22	$1,761
2024	N/R	23	$1,001

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	64	416	$254
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	212	248	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	209	322	$76
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	287	1,203	$57
90935	Hemodialysis procedure with physician evaluation	73	186	$51

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Potassium Chloride	Potassium Chloride	12	774	$822
Torsemide	Torsemide	27	2,070	$632
Levothyroxine Sodium	Levothyroxine Sodium	16	1,380	$300
Calcitriol	Calcitriol	13	1,170	$265
Pravastatin Sodium	Pravastatin Sodium	12	1,080	$226

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$809
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	11	$192

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$340	Travere Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles J. Eldredge, M.D.?

Tedicare shows public-source Medicare data for Charles J. Eldredge, M.D. (NPI 1215989322), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles J. Eldredge, M.D. have ACO affiliation data?

Charles J. Eldredge, M.D. is shown with ACO affiliation data for Bassett Accountable Care Partners, LLC (MSSP, ACO ID A2612), Trinity Health Integrated Care (MSSP, ACO ID A3454), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Charles J. Eldredge, M.D.?

Charles J. Eldredge, M.D. is linked to MOHAWK VALLEY NEPHROLOGY ASSOCIATES, LLP (billing NPI 1548287329) in the available physician profile data.

Does Charles J. Eldredge, M.D. have Open Payments data?

Charles J. Eldredge, M.D. has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.